Ads
related to: sars-cov-2 virus treatment
Search results
New COVID-19 'FLiRT' Variants Are The Most Dominant In The U.S.
Women's Health via AOL· 6 days agoThose who are more vulnerable to getting sick during a spring or summer surge may benefit from the...
What Are The Symptoms Of The New COVID-19 Variants?
IFLScience· 6 days agoThe saucily named COVID-19 FLiRT variants have been surging to global dominance in recent weeks, overtaking the previous leading variant (JN.1) so that...
Virus busting: Improving infection control in healthcare
Digital Journal· 4 hours agoTwo innovations for infection and contamination control are varying the acidity of the air and the application of copper surfaces. A new study shows that aerosols in indoor air can vary in acidity ...
Century-old vaccine found to protect type 1 diabetics from infectious diseases
Medical Xpress· 5 days ago"Individuals with type 1 diabetes are highly susceptible to infectious diseases and had worse outcomes when they were infected with the SARS-CoV-
NBA legend John Stockton has COVID-related 'free speech' lawsuit thrown out by judge
USA TODAY Sports via Yahoo News· 5 days agoIn newspaper articles, for example, the state said Eggleston minimized deaths from the SARS-CoV-2 ...
Study shows vaccination lowers risk of long COVID
Center for Infectious Disease Research and Policy· 5 days agoCOVID-19 patients vaccinated against the novel coronavirus were less likely to have symptoms of post-COVID condition (PCC), or long COVID, according to a...
NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.
The Kansas City Star· 4 days agoSHELTON, CT / ACCESSWIRE / May 23, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, reports that it ...
Hologic, Inc. (NASDAQ:HOLX) Holdings Lowered by Kentucky Retirement Systems
ETF DAILY NEWS· 7 days agoKentucky Retirement Systems lowered its stake in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 3.4% during the fourth quarter, according to its most recent 13F filing with the Securities and ...
Chronic COVID syndrome: a new study shows the positive effects of using Apportal, a targeted...
Nutraingredients.com· 1 day agoThe degree of fatigue and quality of life of these patients were measured three times using specific questionnaires: once before starting to take the supplement, after 14 and then after 28 days ...
From 'loser' to laureate: Nobel winner's advice to young scientists
Nature· 2 days ago“10 years ago, I was considered a loser,” she says. Advice she offers is to follow the work of your...
